用阿法丁尼布稳定了复发性鼻脉瘤:一个病例报告
Christopher C Chen1, Vincent Yeung2
1Internal Medicine, Rutgers New Jersey Medical School, Newark, USA.
Cureus
|December 17, 2025
概括
这个案例研究突出了骨底部附近的罕见骨外胆瘤. 一种EGFR抑制剂阿法替尼 (Afatinib) 显示出作为针对性治疗这种具有挑战性的诊断的潜力.
科学领域:
- 在瘤学瘤学.
- 神经外科 神经外科
- 遗传学 遗传学 是一个
背景情况:
- 冠状瘤是一种罕见的恶性瘤,由冠状腺残留物产生的.
- 骨外软组织冠状瘤,特别是在头骨底部附近,非常罕见.
- 这个病例涉及一个58岁的男性,出现了暗示背质量的症状.
研究的目的:
- 报告一个罕见的骨外胆瘤病例,发生在头骨底部附近.
- 描述患有复发性心脏瘤的患者的诊断和治疗过程.
- 评估针对性治疗的疗效,特别是阿法提尼布,用于晚期心脏瘤.
主要方法:
- 一名58岁的男性接受了对后瘤的横口切除.
- 病理学证实了心脏瘤;患者经历了近10年的复发.
- 治疗包括多次手术,质子束辐射,伊马替尼,达萨替尼和阿法替尼.
主要成果:
- 经过10年多的多次干预,重复性心脏瘤得到了管理.
- 像伊马替尼布和达萨替尼布这样的全身疗法表现出有限的成功.
- 作为表皮生长因子受体 (EGFR) 抑制剂的阿法替尼 (Afatinib) 已被证明是两年来稳定的疾病.
结论:
- 在骨底部附近的骨外瘤非常罕见,并且难以管理.
- 阿法丁尼布代表了对瘤有前途的向治疗选择,特别是当其他治疗方法失败时.
- 这一案例强调了在治疗耐火性心脏瘤方面需要新的治疗策略.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:21Barrett Esophagus-II: Clinical Manifestations and Management
738
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
738